Hepion Pharmaceuticals (HEPA) Financials

$0.06

$-0.02 (-26.67%)

As on 11-Sep-2026 12:53EDT

Market cap

$8 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

41.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	0.03	0.07	0.08	0.09
Gross Profit	--	--	-0.03	-0.07	-0.08	-0.09
Operating Expenses	3.15	4.16	19.35	48.45	45.49	30.40
Operating Profit (EBIT)	-3.15	-4.16	-19.35	-48.45	-45.49	-30.40
Other Income	--	--	--	--	--	--
Profit before Tax	-3.19	-8.28	-16.16	-49.34	-45.08	-32.72
Provision for Tax	--	--	-2.97	-0.41	-2.88	0.01
Profit after Tax (Net Income)	-3.19	-8.28	-13.19	-48.93	-42.20	-32.72
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-45.34	-32.72

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1.28	2.67	-1.86	7.28	49.86	93.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.16	0.10	0.33	5.52	2.50	2.35
Current Liabilities	0.49	0.30	3.14	5.29	7.89	8.21
Total Liabilities	2.42	3.07	1.61	18.09	60.24	103.55

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	0.61	0.61	3.75	6.10
Current Assets	1.93	3.07	1.61	17.49	56.50	97.45
Total Assets	2.42	3.07	1.61	18.09	60.24	103.55
Total Debt*	--	0.05	2.90	0.21	0.05	0.32
Net Current Assets	1.43	2.77	-1.53	12.20	48.61	89.25

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-3.27	-18.22	-40.89	-34.96	-31.22
Cash Flow from Investing Activities	--	-0.13	-0.60	--	-0.01	-0.13
Cash from Financing Activities	--	4.83	4.35	4.49	-5.14	81.98
Net Cash Inflow / Outflow	--	--	--	--	-40.11	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.26	-0.88	-94.77	-507.53	-5.54	-4.29
Cash EPS ($)	--	-0.88	-94.55	-506.77	-5.53	-4.28
Adjusted Book Value ($)	--	0.28	--	75.53	6.54	12.20
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.35	-130.86	-424.16	-4.59	-4.10
Free Cash Flow per Share ($)	--	-0.35	-130.86	-424.31	-4.59	-4.11

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-440.51	-309.45	-170.48	-58.93	-48.63
ROE (%)	-161.60	-2,058.63	-487.03	-171.26	-59.08	-49.02
ROA (%)	-84.82	-353.48	-133.88	-124.91	-51.53	-43.00
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	66.87	74.78	69.76	-9.43	-37.78	-62.38
Net Profit Growth (%)	76.49	37.25	73.04	-15.94	-28.96	-60.77
EPS Growth (%)	99.48	0.99	0.81	-90.68	-0.29	-0.10
Book Value Growth (%)	-76.44	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	0.00	-0.01	-0.05	-0.27
Price / Book Value	41.86	--	-0.04	0.04	0.05	0.09
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.16	--	-0.17	0.29	1.09	2.52
Close Price ($)	0.07	--	23.51	162.00	300.30	1,140.00
High Price ($)	0.11	--	174.50	1,192.70	1,330.00	3,180.00
Low Price ($)	--	--	21.52	127.50	260.00	1,120.00
Market Cap ($ Cr)	7.94	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	-1.56	0.03	0.00	0.00
Short term debt to equity ratio	--	0.02	-1.56	0.02	0.00	0.00
Current Ratio	3.91	10.25	0.51	3.31	7.16	11.88
Quick Ratio	3.91	--	--	--	--	--
Interest Coverage	-108.70	-154.10	-11.96	-5,211.37	-4,434.65	-3,692.66

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	15,253.57	13,642.19	12,051.62	13,087.49
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.